SGI, IDT Team Up to Produce, Market, Commercialize Small Synthetic-Gene Products

Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and Integrated DNA Technologies, Inc. (IDT), a world leader in production and supply of oligonucleotides, announced February 2 that they have entered into an agreement to manufacture, market and commercialize small synthetic gene products.